Suppr超能文献

G蛋白偶联受体的结构多样性及其在药物发现中的意义。

Structural diversity of G protein-coupled receptors and significance for drug discovery.

作者信息

Lagerström Malin C, Schiöth Helgi B

机构信息

Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, BOX 593, 751 24, Uppsala, Sweden.

出版信息

Nat Rev Drug Discov. 2008 Apr;7(4):339-57. doi: 10.1038/nrd2518.

Abstract

G protein-coupled receptors (GPCRs) are the largest family of membrane-bound receptors and also the targets of many drugs. Understanding of the functional significance of the wide structural diversity of GPCRs has been aided considerably in recent years by the sequencing of the human genome and by structural studies, and has important implications for the future therapeutic potential of targeting this receptor family. This article aims to provide a comprehensive overview of the five main human GPCR families--Rhodopsin, Secretin, Adhesion, Glutamate and Frizzled/Taste2--with a focus on gene repertoire, general ligand preference, common and unique structural features, and the potential for future drug discovery.

摘要

G蛋白偶联受体(GPCRs)是最大的膜结合受体家族,也是许多药物的作用靶点。近年来,人类基因组测序和结构研究极大地促进了对GPCRs广泛结构多样性功能意义的理解,这对靶向该受体家族的未来治疗潜力具有重要意义。本文旨在全面概述人类五个主要的GPCR家族——视紫红质、促胰液素、黏附、谷氨酸和卷曲/味觉2家族,重点关注基因库、一般配体偏好、共同和独特的结构特征以及未来药物发现的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验